MedPath

Role of certain oral drug, nasal drops and leech therapy in migraine.

Phase 2
Completed
Conditions
Health Condition 1: G439- Migraine, unspecified
Registration Number
CTRI/2019/07/020001
Lead Sponsor
ational Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients willing to participate in this trial through written informed consent

2. Patients presenting with symptoms of Ardhavabhedaka (migraine), described as per Ayurveda and modern science.

Exclusion Criteria

1. Secondary headaches caused by meningitis, tumors, encephalitis, head and neck trauma, trigeminal neuralgia, cervical spondylitis, refractive errors, sinusitis and other disorders of cranium, neck, eyes, ears, nose, sinuses, teeth etc.

2. Patients with complicated Migraine like status migrainosus, hemiplegic migraine and having any chronic debilitating disease with other neurological pathology.

3. Pregnant and lactating women.

4. Patients suffering from any other major systemic disorders e.g. tuberculosis, cancer, heart disease etc.

5. Patients unfit for Jalaukavacharna such as patients with hemorrhagic diseases (e.g. hemophilia), anaemia, hypotension, severe allergic diathesis and on anticoagulant treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in intensity and frequency of headacheTimepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
Any adverse event reported voluntarily,observed <br/ ><br>or enquired.Timepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath